Patients with Heparin Induced Thrombocytopenia (HIT) have a very high thrombosis risk. They require alternative anticoagulant treatments which increase the bleeding risk. In the absence of a rapid and reliable laboratory assay, many clinicians simply replace heparin based on clinical suspicion only. However, only about 10% of HIT suspicions are actually confirmed by appropriate tests. Current immunoassays can rule out HIT but have limitations, especially a high number of false positive tests, long time to result, complex handling, and reagent wastage. The STic Expert® HIT kits match all laboratory requirements, including reliability (100% Negative Predictive Value), which rules out HIT when combined with the pretest clinical score, and 93% specificity, which reduces false positive results and the number of confirmatory tests required. Results are available in 10 minutes. Easy and ready to use, the unitary test is available 24/7 STAT compliant for laboratories of all sizes. It reduces the cost of HIT outsourcing and eliminates the need for extra equipment. Two packaging sizes are available, 5 tests per kit and 20 tests per kit, with individual tests in blister packs.
Read more

The MiniBeadbeater-24 cell disrupter disrupts and homogenizes all cell types, from bacteria and spores to animal and plant tissues. Cell lysis takes place in sealed 2 ml microvials containing glass or ceramic beads. Nucleic acids and proteins are isolated in 1-2 minutes of bead beating. The ultra-high energy shaking machine processes up to 24 samples, has variable speed for special applications and simple controls. Essential for PCR methodologies, the MiniBeadbeater-24 uses disposable vials and beads, thus eliminating any possibility of cross-contamination between samples.

For more information please click here
Read more

A urinary cytokeratin test (lateral flow) for bladder cancer is now available. Cytokeratin proteins have been implicated as tumour cell activity markers and have demonstrated clinical utility in different epithelial cell carcinomas. UBC® Rapid is a POC test that measures soluble cytokeratin 8/18 fragments in voided urine. It has been showed to increase the detection of new cases of bladder cancer. UBC Rapid can also be used for surveillance after primary surgery and as predictor of recurrence. Studies have shown that the test is a useful adjunct tool to cystoscopy in the evaluation of patients at risk of bladder cancer. The combination UBC® Rapid/OMEGA Reader increases the sensitivity and specificity, making the test a useful marker to identify bladder cancer patients. The UBC® Rapid does not require expert analysis or laboratory time and provides unambiguous results during the patient visit. Its cost is low compared to cytology.
Read more

The fully automated HemosIL AcuStar VWF assay panel, designed exclusively for use on the ACL AcuStar® Hemostasis Testing System, includes HemosIL AcuStar VWF Antigen (VWF:Ag) and HemosIL AcuStar VWF Ristocetin Cofactor (VWF:RCo) Activity assays. This new panel automates and simplifies laboratory testing for von Willebrand disease (VWD), a key part of clinical investigation. Moreover, HemosIL AcuStar VWF:RCo is the first fully automated, chemiluminescent assay to use recombinant technology, allowing full automation and greater precision than platelet-based tests. It meets guidelines on VWD investigation and enhances accuracy versus manual methods. Additionally, chemiluminescence offers an enhanced linearity range to quantify extremely low levels of VWF concentrations. Like all reagents on the ACL AcuStar System, HemosIL AcuStar VWF assays are ready-to-use, cartridge-based and offer results in 30 minutes—on-demand, 24/7. This is the third specialty assay panel commercialized on the ACL AcuStar system and it is currently distributed in the EU and other international territories as a CE IVD Mark product
Read more

A high quality ToRCH panel that is manufactured in the USA and employs ELISA methodology is now available. The Elisa methodology provides excellent sensitivity, specificity, accuracy and precision. The assay kits offered will determine IgG and IgM antibodies to Toxoplasma, IgG and IgM antibodies to Rubella, IgG and IgM antibodies to CMV and IgG antibody to HSV. ToRCH is an acronym for a group of infectious diseases that can cause illness in pregnant women and may cause birth defects in their newborns.
Read more